Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases

The family of mitogen-activated protein kinases (MAPKs) consists of fourteen members and has been implicated in regulation of virtually all cellular processes. MAPKs are divided into two groups, conventional and atypical MAPKs. Conventional MAPKs are further classified into four sub-families: extrac...

Full description

Bibliographic Details
Main Authors: Toufic Kassouf, Grzegorz Sumara
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/9/1256
_version_ 1827707217860624384
author Toufic Kassouf
Grzegorz Sumara
author_facet Toufic Kassouf
Grzegorz Sumara
author_sort Toufic Kassouf
collection DOAJ
description The family of mitogen-activated protein kinases (MAPKs) consists of fourteen members and has been implicated in regulation of virtually all cellular processes. MAPKs are divided into two groups, conventional and atypical MAPKs. Conventional MAPKs are further classified into four sub-families: extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK1, 2 and 3), p38 (α, β, γ, δ), and extracellular signal-regulated kinase 5 (ERK5). Four kinases, extracellular signal-regulated kinase 3, 4, and 7 (ERK3, 4 and 7) as well as Nemo-like kinase (NLK) build a group of atypical MAPKs, which are activated by different upstream mechanisms than conventional MAPKs. Early studies identified JNK1/2 and ERK1/2 as well as p38α as a central mediators of inflammation-evoked insulin resistance. These kinases have been also implicated in the development of obesity and diabetes. Recently, other members of conventional MAPKs emerged as important mediators of liver, skeletal muscle, adipose tissue, and pancreatic β-cell metabolism. Moreover, latest studies indicate that atypical members of MAPK family play a central role in the regulation of adipose tissue function. In this review, we summarize early studies on conventional MAPKs as well as recent findings implicating previously ignored members of the MAPK family. Finally, we discuss the therapeutic potential of drugs targeting specific members of the MAPK family.
first_indexed 2024-03-10T16:42:36Z
format Article
id doaj.art-1ef2d9a6f5634c0bbce2594e2302e4ec
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T16:42:36Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-1ef2d9a6f5634c0bbce2594e2302e4ec2023-11-20T11:52:09ZengMDPI AGBiomolecules2218-273X2020-08-01109125610.3390/biom10091256Impact of Conventional and Atypical MAPKs on the Development of Metabolic DiseasesToufic Kassouf0Grzegorz Sumara1Dioscuri Centre for Metabolic Diseases, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, PolandDioscuri Centre for Metabolic Diseases, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093 Warsaw, PolandThe family of mitogen-activated protein kinases (MAPKs) consists of fourteen members and has been implicated in regulation of virtually all cellular processes. MAPKs are divided into two groups, conventional and atypical MAPKs. Conventional MAPKs are further classified into four sub-families: extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK1, 2 and 3), p38 (α, β, γ, δ), and extracellular signal-regulated kinase 5 (ERK5). Four kinases, extracellular signal-regulated kinase 3, 4, and 7 (ERK3, 4 and 7) as well as Nemo-like kinase (NLK) build a group of atypical MAPKs, which are activated by different upstream mechanisms than conventional MAPKs. Early studies identified JNK1/2 and ERK1/2 as well as p38α as a central mediators of inflammation-evoked insulin resistance. These kinases have been also implicated in the development of obesity and diabetes. Recently, other members of conventional MAPKs emerged as important mediators of liver, skeletal muscle, adipose tissue, and pancreatic β-cell metabolism. Moreover, latest studies indicate that atypical members of MAPK family play a central role in the regulation of adipose tissue function. In this review, we summarize early studies on conventional MAPKs as well as recent findings implicating previously ignored members of the MAPK family. Finally, we discuss the therapeutic potential of drugs targeting specific members of the MAPK family.https://www.mdpi.com/2218-273X/10/9/1256obesitydiabetesMAPKsERK1/2JNKsp38
spellingShingle Toufic Kassouf
Grzegorz Sumara
Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
Biomolecules
obesity
diabetes
MAPKs
ERK1/2
JNKs
p38
title Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
title_full Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
title_fullStr Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
title_full_unstemmed Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
title_short Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
title_sort impact of conventional and atypical mapks on the development of metabolic diseases
topic obesity
diabetes
MAPKs
ERK1/2
JNKs
p38
url https://www.mdpi.com/2218-273X/10/9/1256
work_keys_str_mv AT toufickassouf impactofconventionalandatypicalmapksonthedevelopmentofmetabolicdiseases
AT grzegorzsumara impactofconventionalandatypicalmapksonthedevelopmentofmetabolicdiseases